July 27, 2019 by Matthew LePoire on cancer, Uncategorized 044 – Marker Therapeutics DISAPPOINTS in pancreatic cancer Hi all, today I talk about the #MRKR interim update of their MultiTAA treatment in pancreatic cancer. I go through the data in all 3 arms and analyze whether or not they see an actual effect of their unique therapy. *this is not investment advice* #breaking biotech #biotech Share this:Click to share on Facebook (Opens in new window)Click to share on Twitter (Opens in new window)Like this:Like Loading...
April 29, 2019 by Matthew LePoire on cancer, Uncategorized 039 – Will Marker Therapeutics Succeed in Pancreatic Cancer? Hi everybody, in this episode I take a deeper dive into pancreatic cancer and how Marker Therapeutics’ MultiTAA T Cell therapy might fare against it. Thanks for watching! Follow me on twitter @matthewlepoire Note: *This is not investment advice* Share this:Click to share on Facebook (Opens in new window)Click to share on Twitter (Opens in new window)Like this:Like Loading...
